Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
April 28, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
ZTS
Canada Cannabis Update: Health Recall, Home Cultivation Ban Reversal, International Expansion
April 26, 2024
Via
Benzinga
Topics
Cannabis
Product Recall
Exposures
Cannabis
Legal
Product Safety
Tickers
CSE:GWAY
GWAYF
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
April 26, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
April 26, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
April 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CSLLY
PFE
Altria CEO Urges FDA Crackdown On Illicit Vape Products: Report
April 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
HDV
MO
VTI
Soap Mishap Causes Tesla to Recall Thousands of Cybertrucks
April 26, 2024
Via
Investor Brand Network
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
April 26, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
PFE
QURE
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference
April 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CYBN
HLT
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
April 25, 2024
Via
News Direct
Exposures
Product Safety
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
April 25, 2024
Via
TheNewswire.com
Exposures
Product Safety
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
April 24, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
ZTS
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
April 24, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
ZTS
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
April 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BIIB
ESALY
Best Therapists Carlton North Melbourne Delivers Psychodynamic Psychotherapy - Maple Tree Counselling Announcement
April 24, 2024
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
April 24, 2024
Via
News Direct
Exposures
Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
April 24, 2024
Via
TheNewswire.com
Exposures
Product Safety
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
April 24, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GILD
HOOK
RHHBY
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
April 24, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PXMD
AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals
April 24, 2024
Via
News Direct
Exposures
Product Safety
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
April 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVS
What Analysts Are Saying About PepsiCo's Q1 Earnings?
April 23, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
GS
PEP
Lisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumors
April 23, 2024
Via
TheNewswire.com
Exposures
Product Safety
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CSE:INNO
INNO
INNPF
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
April 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
IBRX
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
April 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ABEO
Bay Area Start-Up Brings the Power of AI to Breast Cancer Screening
April 23, 2024
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
April 23, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
ABEO
HWH
PEGY
Mayo Clinic Diet Survey Spotlights Important Correlation Between Weight Loss Medication and Behavioral Support Programs
April 23, 2024
Via
PRUnderground
Exposures
Product Safety
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
April 22, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
BLUE
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.